CorMedix Inc. — Director's Dealing 2011

Mar 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CorMedix Inc. (CRMD)
CIK: 0001410098
Period of Report: 2011-03-01

Reporting Person: Klausner Mark A. (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-03-01	Stock option (right to buy)	$1.61	A	356000	Acquired	2021-03-01	Common Stock, $0.001 par value per share (356000)	Direct

Footnotes

F1: These options vest as follows: 1/3 on March 1, 2012; an additional 1/3 on March 1, 2013; and the remaining 1/3 on March 1, 2014.